Todays Report: The Brokerages Set CME Group Inc. (CME) PT at $102.21

The Brokerages Set CME Group Inc. (CME) PT at $102.21

CME Group Inc. (NASDAQ:CME) has received an average rating of “Hold” from the thirteen analysts that are currently covering the company. Two analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $102.21.

A number of equities analysts have commented on CME shares. Credit Agricole SA reduced their price objective on shares of CME Group from $100.00 to $95.00 and set an “underperform” rating for the company in a research report on Thursday, July 14th. Zacks Investment Research raised shares of CME Group from a “hold” rating to a “buy” rating and set a $116.00 price objective for the company in a research report on Thursday, August 4th. Jefferies Group lifted their price objective on shares of CME Group from $112.00 to $118.00 and gave the stock a “buy” rating in a research report on Wednesday, August 31st. Deutsche Bank AG lifted their price objective on shares of CME Group from $111.00 to $112.00 and gave the stock a “buy” rating in a research report on Friday, August 5th. Finally, Keefe, Bruyette & Woods lifted their price objective on shares of CME Group from $99.00 to $103.00 and gave the stock a “market perform” rating in a research report on Friday, July 29th.

Shares of CME Group (NASDAQ:CME) opened at 105.44 on Wednesday. CME Group has a 12-month low of $81.87 and a 12-month high of $110.35. The stock has a 50 day moving average of $106.48 and a 200 day moving average of $99.70. The company has a market cap of $35.73 billion, a price-to-earnings ratio of 26.63 and a beta of 0.83.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Thursday, July 28th. The company reported $1.14 EPS for the quarter, topping the Zacks’ consensus estimate of $1.11 by $0.03. CME Group had a net margin of 38.22% and a return on equity of 6.83%. The firm earned $906 million during the quarter, compared to analysts’ expectations of $897.84 million. During the same period in the previous year, the business posted $0.95 earnings per share. The company’s revenue for the quarter was up 10.5% compared to the same quarter last year. On average, equities analysts expect that CME Group will post $4.43 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Monday, September 26th. Investors of record on Friday, September 9th were paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date was Wednesday, September 7th. CME Group’s dividend payout ratio (DPR) is presently 60.61%.

In related news, insider Kimberly S. Taylor sold 2,300 shares of the business’s stock in a transaction dated Thursday, September 29th. The stock was sold at an average price of $106.01, for a total value of $243,823.00. Following the completion of the transaction, the insider now owns 105,558 shares of the company’s stock, valued at $11,190,203.58. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Hilda Harris Piell sold 893 shares of the business’s stock in a transaction dated Monday, September 19th. The shares were sold at an average price of $110.00, for a total value of $98,230.00. Following the completion of the transaction, the insider now directly owns 29,125 shares of the company’s stock, valued at approximately $3,203,750. The disclosure for this sale can be found here. 0.61% of the stock is owned by corporate insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Bank of Montreal Can acquired a new position in shares of CME Group during the second quarter valued at approximately $35,643,000. Legal & General Group Plc increased its position in shares of CME Group by 2.0% in the first quarter. Legal & General Group Plc now owns 1,391,482 shares of the company’s stock valued at $133,643,000 after buying an additional 27,322 shares during the last quarter. AMP Capital Investors Ltd increased its position in shares of CME Group by 10.6% in the first quarter. AMP Capital Investors Ltd now owns 278,973 shares of the company’s stock valued at $26,661,000 after buying an additional 26,751 shares during the last quarter. UMB Bank N A MO increased its position in shares of CME Group by 5.8% in the second quarter. UMB Bank N A MO now owns 177,713 shares of the company’s stock valued at $17,309,000 after buying an additional 9,775 shares during the last quarter. Finally, Strs Ohio increased its position in shares of CME Group by 5.2% in the second quarter. Strs Ohio now owns 234,783 shares of the company’s stock valued at $22,867,000 after buying an additional 11,596 shares during the last quarter. 80.29% of the stock is owned by institutional investors and hedge funds.

Related posts

Leave a Comment